Twenty-five years ago my doctors had no cure for my cancer. So I went on a quest to find my own treatment. This is my story...

In 1991, Glenn Sabin was a 28-year-old newlywed diagnosed with chronic lymphocytic leukemia (CLL)-a disease doctors called "uniformly fatal." Treatments could buy him some time and eventually ease his discomfort, but there was no conventional cure. Glenn's prognosis was clear: he was going to die.

Although Glenn and his wife, Linda, continued to consult with doctors, cancer specialists and top oncologists, Glenn made a monumental decision: he would become his own health advocate. While he continued to "watch and wait," Glenn would figure out how to stay alive.

No one could predict when a large-scale clinical trial would discover a cure for CLL, so Glenn began his own, medically monitored and carefully researched lifestyle changes. He would conduct his own, single patient clinical trial.

He would become an "n of 1."

Today, Glenn is not only alive, but a 2012 biopsy at Harvard confirmed that his bone marrow contains no leukemic cells. His case is now part of the medical literature.

In n of 1, author Glenn Sabin takes readers along his remarkable journey with 'incurable' cancer, where he discovers:

• No two cancers are exactly alike. Our bodies, minds and diseases are unique, and need to be treated as such.
• Knowledge and empowerment are your best allies against a life-limiting diagnosis.
• Lifestyle changes are a powerful way to help prevent, manage and reduce the recurrence of disease--and to improve your quality of life.
• A strong support system and a clear mind may significantly improve your health.

https: //www.glennsabin.com

Twitter: @GlennSabin

LinkedIn: https: //www.linkedin.com/in/glennsabin/

Formato	Tapa suave
Número de Páginas	214
Lenguaje	Inglés
Editorial	Fon Press
Fecha de Publicación	2016-11-15
Dimensiones	9.0" x 6.0" x 0.45" pulgadas
Letra Grande	No
Con Ilustraciones	Si
Temas	Salud y Condición Física, Nueva Era

Lemanne Mph, Dawn

Dr. Dawn Lemanne, n of 1 co-author with Glenn Sabin, is a practicing oncologist and integrative medicine authority. One of a small but growing number of oncologists integrating conventional and complementary therapies to treat cancer, Dr. Lemanne approaches each patient as an n of 1. Her practice draws patients from around the globe. Dr. Lemanne is a proponent of rigorous single-subject research design development and is active in the quantified self movement. The first medical oncologist to serve on the faculty of New York's Memorial Sloan Kettering Cancer Center's integrative medicine service, she currently teaches physicians in the University of Arizona's flagship integrative medicine fellowship. She is the author of peer-reviewed scientific articles, textbook chapters, and works for the popular press. Dr. Lemanne speaks by invitation domestically and internationally. After earning the MD degree at the University of California, San Francisco, Dr. Lemanne trained in medical oncology at Stanford University and in integrative medicine at the University of Arizona. She also holds advanced degrees from UC Berkeley and Johns Hopkins University. Dr. Lemanne practices at Oregon Integrative Oncology, in Ashland, Oregon. You can learn more about Dr. Lemanne's work at www.oregonio.com

Sabin, Glenn

In the early 1990s, Glenn Sabin began to develop a comprehensive and highly personalized approach to managing his chronic lymphocytic leukemia (CLL)-a disease his doctors said was incurable and would eventually take his life. Today, Glenn is alive and thriving and he has achieved a complete, medically documented remission of his CLL without conventional treatments. Glenn's remarkable case has been chronicled by Dana-Farber Cancer Institute oncologist Lee M. Nadler, MD, Dean for Clinical and Translational Medicine at Harvard Medical School, and his local Johns Hopkins oncologist Bruce R. Kressel, MD. To say Glenn's 1991 diagnosis was life-altering would be an understatement. Not only has Glenn overcome his cancer and become a staunch advocate of evidence-based, integrative medicine, in 2009 he sold his media and marketing company to launch FON Consulting-a business that supports integrative health and medicine enterprises and helps to accelerate their growth. A past board member of The Society for Integrative Oncology and an author, speaker and collaborator, Glenn is a respected thought leader who works with passion and dedication to advance the field of integrative oncology. Learn more at www.glennsabin.com